z-logo
open-access-imgOpen Access
Hepatitis B Virus Infection Is Associated With Impaired Immunological Recovery During Antiretroviral Therapy in the Swiss HIV Cohort Study
Author(s) -
Gilles Wandeler,
Thomas Gsponer,
Florian Bihl,
Enos Bernasconi,
Matthias Cavassini,
Helen Kovari,
Patrick Schmid,
Manuel Battegay,
Alexandra Calmy,
Matthias Egger,
Hansjakob Furrer,
Andri Rauch,
Vincent Aubert,
Julia M. I. Barth,
J Böni,
Heiner C. Bucher,
Claudine BurtonJeangros,
Luigia Elzi,
Jan Fehr,
Jacques Fellay,
P Francioli,
Christoph A. Fux,
Meri Gorgievski,
H. Günthard,
David Haerry,
Barbara Hasse,
Hans H. Hirsch,
B Hirschel,
Irène Hösli,
Christian R. Kahlert,
Laurent Kaiser,
Olivia Keiser,
Christian Kind,
Thomas Klimkait,
Bruno Ledergerber,
G Martinetti,
Begoña Martínez de Tejada,
Karin J. Metzner,
Nora Müller,
David Nadal,
Giuseppe Pantaleo,
Stephan Regenass,
Martin Rickenbach,
C Rudin,
D. Schultze,
F. Schöni-Affolter,
Jörg Schüpbach,
René Speck,
Patrick Taffé,
Philip Tarr,
A. Telenti,
Alexandra Trkola,
P Vernazza,
Rachel Weber,
Sabine Yerly
Publication year - 2013
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jit351
Subject(s) - coinfection , medicine , hepatitis b virus , virology , immunology , hepatitis b , serology , cohort , viral disease , orthohepadnavirus , virus , hepadnaviridae , antibody
Hepatitis B virus (HBV) infection is a major cause of morbidity and mortality in human immunodeficiency virus (HIV)-infected patients worldwide. It is unclear whether HIV-related outcomes are affected by HBV coinfection. We compared virological suppression and immunological recovery during antiretroviral therapy (ART) of patients of different HBV serological status in the Swiss HIV Cohort Study. CD4 cell recovery during ART was significantly impaired in hepatitis B surface antigen-positive patients and in those with anti-hepatitis B core antigen alone compared with HBV-uninfected patients, despite similar virological efficacy of ART. CD4 increase in patients with resolved HBV infection was similar to that in HBV-uninfected individuals.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom